Navigation Links
Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
Date:3/11/2008

SOUTH SAN FRANCISCO, Calif., March 11 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics (MAbs) for cancer, today announced that an abstract detailing results from the RAV12 Phase 1/2a trial has been accepted as a poster discussion presentation at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO). The presentation is scheduled for May 30, 2008. Dr. Nancy Lewis of the Fox Chase Cancer Center is the abstract's first author and will make the presentation on behalf of the study's participating investigators.

The study, which enrolled 53 patients with adenocarcinomas bearing the RAAG12 antigen, particularly those of gastrointestinal (GI) origin, was conducted at 5 institutions in the US, the Sarah Cannon Cancer Center in Nashville, TN; the Fox Chase Cancer Center in Philadelphia, PA; Premiere Oncology in Santa Monica, CA; the University of Miami Medical Center in Miami, FL; and the Georgetown University Medical Center in Washington, DC.

About GI Cancers

Adenocarcinomas are malignant tumors of the epithelial cells that line glands or viscera. They typically spread by way of the circulatory or lymphatic systems and are poorly treated after metastatic dissemination. More than 90 percent of colon, stomach and pancreatic tumor specimens express the RAV12-defined antigen, RAAG12. Adenocarcinomas arising elsewhere, such as breast, endometrial, ovarian, lung and prostate, display the antigen at lower frequency.

About RAV12

RAV12 is a novel, chimeric monoclonal antibody that is directed against a primate-specific glycotope (sugar structure) that is widely displayed on the surfaces of tumor cells, particularly those of gastrointestinal origin (gastroesophageal, pancreatic, and colorectal cancers). Preclinical studies have demonstrated that RAV12 may kill tumor cells in a number of ways: first, the antibody is directly c
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
2. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
3. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
4. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
5. First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
8. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
9. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
10. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey Riley ... OneMedForum New York Conference on Thursday, June 27, 2013 at ... . Mr. Riley is scheduled to present at 8:40 a.m. ... presentation can be accessed by logging onto the web at ...
(Date:6/19/2013)... June 19, 2013  Continuing its long history of ... Beckman Coulter , Inc. announces the U.S. Food ... Access AccuTnI+3 troponin I assay for use on its ... depended on Beckman Coulter,s troponin I test ... has the proven performance to continue providing dependability to ...
(Date:6/19/2013)... D.C. (PRWEB) June 19, 2013 Bayer ... its first Bayer Bee Care Community Leadership Award. The ... Week Congressional Reception in Washington, D.C., an event ... make to the world’s food supply. , The ... have harnessed the power of the honey bee colony ...
(Date:6/19/2013)... ANGELES , June 19, 2013 Biotechnology industry ... teaming up with financial software provider BlackLine Systems ... SAP ) for a webinar next week entitled ... Uses Solutions from BlackLine and SAP to Help Keep Its ... (Logo: http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4
... 2012  Superior Controls, Inc. has been named "System ... magazine.  Each year, the worldwide competition recognizes the ... expertise, business skills and customer satisfaction. A panel ... from industrial systems integrators throughout the world. 
 ...
...  Healthpoint Biotherapeutics today announced that Travis E. Baugh, President ... President, Strategic and Commercial Development, will present an overview ... pipeline at the upcoming J.P. Morgan Healthcare Conference. The ... am (PST) at the Westin St. Francis Hotel in ...
... WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, ... corporate presentation at the 5 th Annual OneMedForum ... San Francisco, Calif., January 9-12, 2012. The ... 2012 beginning at 10:00 a.m. Pacific Time.  The presentation ...
Cached Biology Technology:Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine 2WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012 2
(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... D.C. June 18, 2013 Joshua Obar, Ph.D., ... has been honored with a 2013 ICAAC Young Investigator ... regulation of immunological memory responses to infection. , ... University in 2001 and went on to complete his ... 2006. He performed his Ph.D. thesis research in ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4The American Society for Microbiology honors Joshua Obar 2
... Healthy ecosystems that provide people with essential natural ... biological diversity, underscoring that conserving one also protects the ... Titled Global Conservation of Biodiversity and Ecosystem Services, the ... priority for conservation efforts. It shows that more ...
... will receive the 2007 EMBO Installation Grants, assisting them ... Croatia, the Czech Republic, Hungary, Poland, Portugal and Turkey. ... since the European Molecular Biology Organization (EMBO) introduced the ... annually and aim to strengthen science in selected member ...
... growth, climate change, high energy prices, globalization, and ... markets, and consumption, according to a new report ... As a result, global food demand and prices ... nutrition of poor people in developing countries. The ...
Cached Biology News:New study finds biodiversity conservation secures ecosystem services for people 2EMBO Installation Grants help 9 scientists set up in Europe 2Rising food prices threaten world's poor people 2Rising food prices threaten world's poor people 3Rising food prices threaten world's poor people 4